{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:31:07Z","timestamp":1761748267855,"version":"build-2065373602"},"reference-count":120,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780128039083"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1016\/bs.enz.2015.09.003","type":"book-chapter","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T07:46:11Z","timestamp":1447141571000},"page":"117-143","source":"Crossref","is-referenced-by-count":4,"title":["Naturally Occurring Missense Mutation in Plasma PAF-AH Among the Japanese Population"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.enz.2015.09.003_bb0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0090-1229(80)90044-6","article-title":"Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF)","volume":"15","author":"Farr","year":"1980","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0010","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.4049\/jimmunol.136.9.3441","article-title":"Substrate specificity and partial characterization of the PAF-acylhydrolase in human serum that rapidly inactivates platelet-activating factor","volume":"136","author":"Wardlow","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0015","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1016\/S0021-9258(18)61335-3","article-title":"Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor","volume":"262","author":"Stafforini","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2015.09.003_bb0020","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/S0021-9258(18)61336-5","article-title":"Human plasma platelet-activating factor acetylhydrolase. Purification and properties","volume":"262","author":"Stafforini","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2015.09.003_bb0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/374549a0","article-title":"Anti-inflammatory properties of a platelet-activating factor acetylhydrolase","volume":"374","author":"Tjoelker","year":"1995","journal-title":"Nature"},{"key":"10.1016\/bs.enz.2015.09.003_bb0030","doi-asserted-by":"crossref","first-page":"25481","DOI":"10.1074\/jbc.270.43.25481","article-title":"Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad","volume":"270","author":"Tjoelker","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2015.09.003_bb0035","doi-asserted-by":"crossref","first-page":"31617","DOI":"10.1074\/jbc.M804750200","article-title":"Crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis","volume":"283","author":"Samanta","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2015.09.003_bb0040","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1074\/jbc.274.11.7018","article-title":"Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein","volume":"274","author":"Stafforini","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2015.09.003_bb0045","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1172\/JCI118733","article-title":"Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase","volume":"97","author":"Stafforini","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.enz.2015.09.003_bb0050","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1172\/JCI113818","article-title":"Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children","volume":"82","author":"Miwa","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.enz.2015.09.003_bb0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1291\/hypres.30.403","article-title":"Comprehensive evaluation of genetic and environmental factors influencing the plasma lipoprotein-associated phospholipase A2 activity in a Japanese population","volume":"30","author":"Zhang","year":"2007","journal-title":"Hypertens. Res."},{"key":"10.1016\/bs.enz.2015.09.003_bb0060","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s10038-004-0151-6","article-title":"Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patients","volume":"49","author":"Ishihara","year":"2004","journal-title":"J. Hum. Genet."},{"key":"10.1016\/bs.enz.2015.09.003_bb0065","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1006\/bbrc.1997.7047","article-title":"Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281\u2192Arg mutation","volume":"236","author":"Yamada","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.enz.2015.09.003_bb0070","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1210\/jc.2006-0116","article-title":"The Val279Phe variant of the lipoprotein-associated phospholipase A2 gene is associated with catalytic activities and cardiovascular disease in Korean men","volume":"91","author":"Jang","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.enz.2015.09.003_bb0075","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1538-7836.2006.01895.x","article-title":"Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction","volume":"4","author":"Liu","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/bs.enz.2015.09.003_bb0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0049-3848(00)00394-7","article-title":"Evidence for the existence of the PAF acetylhydrolase mutation (Val279Phe) in non-Japanese populations: a preliminary study in Turkey, Azerbaijan, and Kyrgyzstan","volume":"101","author":"Balta","year":"2001","journal-title":"Thromb. Res."},{"key":"10.1016\/bs.enz.2015.09.003_bb0085","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1086\/302901","article-title":"The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma","volume":"66","author":"Kruse","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/bs.enz.2015.09.003_bb0090","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0021-9150(03)00086-8","article-title":"Association between the Ala379Val variant of the lipoprotein associated phospholipase A2 and risk of myocardial infarction in the north and south of Europe","volume":"168","author":"Abuzeid","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.enz.2015.09.003_bb0095","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/hmg\/ddh145","article-title":"Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease","volume":"13","author":"Ninio","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/bs.enz.2015.09.003_bb0100","doi-asserted-by":"crossref","first-page":"11095","DOI":"10.1016\/S0021-9258(18)99132-5","article-title":"Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates","volume":"266","author":"Stremler","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2015.09.003_bb0105","doi-asserted-by":"crossref","first-page":"22308","DOI":"10.1074\/jbc.270.38.22308","article-title":"Purification and characterization of platelet-activating factor acetylhydrolase II from bovine liver cytosol","volume":"270","author":"Hattori","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2015.09.003_bb0110","doi-asserted-by":"crossref","first-page":"13597","DOI":"10.1074\/jbc.272.21.13597","article-title":"Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte\/endothelial interactions and evidence for their presence in vivo","volume":"272","author":"Watson","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2015.09.003_bb0115","doi-asserted-by":"crossref","first-page":"12010","DOI":"10.1073\/pnas.96.21.12010","article-title":"Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils","volume":"96","author":"Leitinger","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.enz.2015.09.003_bb0120","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1194\/jlr.M500074-JLR200","article-title":"Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation","volume":"46","author":"Androulakis","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/bs.enz.2015.09.003_bb0125","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ajh.2009.70","article-title":"Effects of G994T in the Lp-PLA2 gene on the plasma oxidized LDL level and carotid intima-media thickness in Japanese: the Shimane study","volume":"22","author":"Wang","year":"2009","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/bs.enz.2015.09.003_bb0130","doi-asserted-by":"crossref","first-page":"52425","DOI":"10.1074\/jbc.M410967200","article-title":"Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I \u03b12 catalytic subunit","volume":"279","author":"Bonin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2015.09.003_bb0135","doi-asserted-by":"crossref","first-page":"24842","DOI":"10.1074\/jbc.M702865200","article-title":"Cytotoxic phospholipid oxidation products. Cell death from mitochondrial damage and the intrinsic caspase cascade","volume":"282","author":"Chen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2015.09.003_bb0140","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1194\/jlr.R800024-JLR200","article-title":"The emerging roles of PAF acetylhydrolase","volume":"50","author":"McIntyre","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/bs.enz.2015.09.003_bb0145","doi-asserted-by":"crossref","first-page":"32315","DOI":"10.1074\/jbc.272.51.32315","article-title":"Protection against oxidative stress-induced cell death by intracellular platelet-activating factor acetylhydrolase II","volume":"272","author":"Matsuzawa","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2015.09.003_bb0150","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1523-1747.2002.01859.x","article-title":"Identification of platelet-activating factor acetylhydrolase II in human skin","volume":"119","author":"Marques","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0155","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/(SICI)1097-4547(19980915)53:6<677::AID-JNR6>3.0.CO;2-2","article-title":"Recombinant plasma-type platelet-activating factor acetylhydrolase attenuates NMDA-induced hippocampal neuron apoptosis","volume":"53","author":"Ogden","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/bs.enz.2015.09.003_bb0160","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0006-8993(00)02852-3","article-title":"Transfection of the plasma-type platelet-activating factor acetylhydrolase gene attenuates glutamate-induced apoptosis in cultured rat cortical neurons","volume":"885","author":"Hirashima","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/bs.enz.2015.09.003_bb0165","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-2249.2001.01483.x","article-title":"The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase","volume":"123","author":"Kuijpers","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0170","doi-asserted-by":"crossref","first-page":"839","DOI":"10.5551\/jat.21386","article-title":"Lipoprotein-associated phospholipase A2 regulates macrophage apoptosis via the Akt and caspase-7 pathways","volume":"21","author":"Maeda","year":"2014","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/bs.enz.2015.09.003_bb0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-5793(03)01007-X","article-title":"Mildly oxidised LDL induces more macrophage death than moderately oxidised LDL: roles of peroxidation, lipoprotein-associated phospholipase A2 and PPARgamma","volume":"553","author":"Carpenter","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/bs.enz.2015.09.003_bb0180","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.108.806158","article-title":"Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage","volume":"119","author":"Gautier","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/bs.enz.2015.09.003_bb0185","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bbalip.2006.05.008","article-title":"Plasma PAF-acetylhydrolase: an unfulfilled promise?","volume":"1761","author":"Karabina","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/bs.enz.2015.09.003_bb0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0026-0495(98)90216-5","article-title":"Identification of the G994 \u279d T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men","volume":"47","author":"Yamada","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/bs.enz.2015.09.003_bb0195","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1161\/01.STR.28.12.2417","article-title":"A mutation in plasma platelet-activating factor acetylhydrolase (Val279 \u279d Phe) is a genetic risk factor for stroke","volume":"28","author":"Hiramoto","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/bs.enz.2015.09.003_bb0200","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/01.CIR.98.18.1881","article-title":"Association of a G994 \u279d T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese","volume":"98","author":"Ichihara","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/bs.enz.2015.09.003_bb0205","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s100380170042","article-title":"Association of a G994 \u279d T (Val279 \u279d Phe) polymorphism of the plasma platelet-activating factor acetylhydrolase gene with myocardial damage in Japanese patients with nonfamilial hypertrophic cardiomyopathy","volume":"46","author":"Yamada","year":"2001","journal-title":"J. Hum. Genet."},{"key":"10.1016\/bs.enz.2015.09.003_bb0210","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0037-1615214","article-title":"A mutation in plasma platelet-activating factor acetylhydrolase (Val279Phe) is a genetic risk factor for cerebral hemorrhage but not for hypertension","volume":"80","author":"Yoshida","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/bs.enz.2015.09.003_bb0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00385-8","article-title":"Correlation between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population","volume":"150","author":"Yamada","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.enz.2015.09.003_bb0220","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1067\/mva.2000.105670","article-title":"Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in Japan","volume":"32","author":"Unno","year":"2000","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/bs.enz.2015.09.003_bb0225","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1067\/msy.2002.124931","article-title":"Single nucleotide polymorphism (G994 \u279d T) in the plasma platelet-activating factor acetylhydrolase gene is associated with graft patency of femoropopliteal bypass","volume":"132","author":"Unno","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/bs.enz.2015.09.003_bb0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2003.09.019","article-title":"Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia","volume":"172","author":"Shimokata","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.enz.2015.09.003_bb0235","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/hr.2009.151","article-title":"Association of PLA2G7 polymorphisms with carotid atherosclerosis in hypertensive Japanese","volume":"32","author":"Miwa","year":"2009","journal-title":"Hypertens. Res."},{"key":"10.1016\/bs.enz.2015.09.003_bb0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00439-008-0587-4","article-title":"Association of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study","volume":"125","author":"Hou","year":"2009","journal-title":"Hum. Genet."},{"key":"10.1016\/bs.enz.2015.09.003_bb0285","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1161\/01.CIR.103.20.2495","article-title":"Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice","volume":"103","author":"Quarck","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/bs.enz.2015.09.003_bb0290","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/01.ATV.0000067701.09398.18","article-title":"Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress","volume":"23","author":"Noto","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0295","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1161\/CIRCULATIONAHA.104.476242","volume":"111","author":"Arakawa","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/bs.enz.2015.09.003_bb0300","doi-asserted-by":"crossref","first-page":"II 365","DOI":"10.1161\/circ.100.suppl_2.Ii-365","article-title":"Platelet-activating factor acetylhydrolase prevents myocardial ischemia-reperfusion injury","volume":"100","author":"Morgan","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/bs.enz.2015.09.003_bb0305","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0021-9150(99)00406-2","article-title":"Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease","volume":"150","author":"Caslake","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.enz.2015.09.003_bb0310","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","article-title":"Lipoprotein-associated phospholipase A2, as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group","volume":"343","author":"Packard","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.enz.2015.09.003_bb0315","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1161\/01.CIR.0000143377.53389.C8","article-title":"Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany","volume":"110","author":"Koenig","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/bs.enz.2015.09.003_bb0320","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0735-1097(01)01554-6","article-title":"A prospective evaluation of lipoprotein-associated phospholipase A2 levels and the risk of future cardiovascular events in women","volume":"38","author":"Blake","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0325","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0009-8981(91)90260-J","article-title":"Platelet-activating factor acetylhydrolase in plasma lipoproteins of healthy men and women","volume":"202","author":"Satoh","year":"1991","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/bs.enz.2015.09.003_bb0330","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.CIR.0000116763.91992.F1","article-title":"Lipoprotein-associated phospholipase A2, high sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study","volume":"109","author":"Ballantyne","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/bs.enz.2015.09.003_bb0335","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.CIR.0000154553.12214.CD","article-title":"Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study","volume":"111","author":"Oei","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/bs.enz.2015.09.003_bb0340","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1194\/jlr.M300086-JLR200","article-title":"Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis","volume":"44","author":"Blankenberg","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/bs.enz.2015.09.003_bb0345","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2009.10.041","article-title":"Lipoprotein-associated phospholipase A2, inflammatory biomarkers, and risk of cardiovascular disease in the prospective study of pravastatin in the elderly at risk (PROSPER)","volume":"210","author":"Caslake","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.enz.2015.09.003_bb0350","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1161\/01.ATV.0000222983.73369.c8","article-title":"Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress","volume":"26","author":"Koenig","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0355","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/CIRCULATIONAHA.105.612630","volume":"113","author":"O\u2019Donoghue","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/bs.enz.2015.09.003_bb0360","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/eurheartj\/ehi010","article-title":"Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up","volume":"26","author":"Brilakis","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/bs.enz.2015.09.003_bb0365","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ncpcardio0321","article-title":"Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke","volume":"2","author":"Caslake","year":"2005","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/bs.enz.2015.09.003_bb0370","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1001\/archinte.165.21.2479","article-title":"Lipoprotein-associated phospholipase A2, high sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study","volume":"165","author":"Ballantyne","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/bs.enz.2015.09.003_bb0375","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/eurheartj\/ehl230","article-title":"Lipoprotein-associated phospholipase A2 activity and risk of heart failure: the Rotterdam Study","volume":"27","author":"van Vark","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/bs.enz.2015.09.003_bb0380","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1073\/pnas.85.8.2805","article-title":"Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis","volume":"85","author":"Quinn","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.enz.2015.09.003_bb0385","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1172\/JCI115932","article-title":"Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells","volume":"90","author":"Kume","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.enz.2015.09.003_bb0390","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1172\/JCI117776","article-title":"Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells","volume":"95","author":"Khan","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.enz.2015.09.003_bb0395","doi-asserted-by":"crossref","first-page":"17791","DOI":"10.1074\/jbc.271.30.17791","article-title":"Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2","volume":"271","author":"Chai","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2015.09.003_bb0400","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.98.4.353","article-title":"Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration","volume":"98","author":"Kohno","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/bs.enz.2015.09.003_bb0405","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/01.ATV.16.4.600","article-title":"Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages","volume":"16","author":"Sakai","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0410","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/344160a0","article-title":"Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins","volume":"344","author":"Kugiyama","year":"1990","journal-title":"Nature"},{"key":"10.1016\/bs.enz.2015.09.003_bb0415","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/01.ATV.15.12.2290","article-title":"Lysophosphatidylcholine inhibits relaxation of rabbit abdominal aorta mediated by endothelium-derived nitric oxide and endothelium-derived hyperpolarizing factor independent of protein kinase C activation","volume":"15","author":"Cowan","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0420","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0021-9150(98)00297-4","article-title":"Lysophosphatidylcholine activates mitogen-activated protein kinases by a tyrosine kinase-dependent pathway in bovine aortic endothelial cells","volume":"143","author":"Ozaki","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.enz.2015.09.003_bb0425","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/(SICI)1096-9888(200002)35:2<224::AID-JMS933>3.0.CO;2-G","article-title":"Analysis of oxidized glycerophosphocholine lipids using electrospray ionization mass spectrometry and microderivatization techniques","volume":"35","author":"Harrison","year":"2000","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/bs.enz.2015.09.003_bb0430","doi-asserted-by":"crossref","first-page":"38517","DOI":"10.1074\/jbc.M205924200","article-title":"A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions","volume":"277","author":"Podrez","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2015.09.003_bb0435","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.ATV.0000051407.42536.73","article-title":"Phospholipid hydroxyalkenals: biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions","volume":"23","author":"Hoff","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0440","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/01.ATV.0000244681.72738.bc","article-title":"Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis","volume":"26","author":"Kolodgie","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0445","doi-asserted-by":"crossref","first-page":"40676","DOI":"10.1074\/jbc.M507787200","article-title":"Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A","volume":"49","author":"Obinata","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2015.09.003_bb0450","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1161\/01.ATV.0000246774.02426.71","article-title":"Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice","volume":"26","author":"Parks","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0455","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/bj3380479","article-title":"Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor","volume":"338","author":"Macphee","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/bs.enz.2015.09.003_bb0460","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/nm.1870","article-title":"Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development","volume":"14","author":"Wilensky","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/bs.enz.2015.09.003_bb0465","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-control trial","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/bs.enz.2015.09.003_bb0470","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1164\/ajrccm\/136.5.1145","article-title":"The bronchoconstrictor properties of platelet-activating factor in humans","volume":"136","author":"Rubin","year":"1987","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/bs.enz.2015.09.003_bb0475","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1164\/ajrccm\/143.5_Pt_2.S86","article-title":"Eicosanoids and platelet-activating factor in allergic respiratory diseases","volume":"143","author":"Henderson","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/bs.enz.2015.09.003_bb0480","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0090-6980(87)90295-4","article-title":"Effect of BN52063, a specific PAF-acether antagonist, on bronchial provocation test to allergens in asthmatic patients. A preliminary study","volume":"34","author":"Guinot","year":"1987","journal-title":"Prostaglandins"},{"key":"10.1016\/bs.enz.2015.09.003_bb0485","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0014-2999(82)90373-9","article-title":"Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig","volume":"78","author":"Chignard","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0490","first-page":"277","article-title":"Effects of platelet-activating factor on tracheal mucus secretion, on airway mechanics and on circulating blood cells in liver ferrets","volume":"146","author":"Hahn","year":"1986","journal-title":"Eur. J. Respir. Dis."},{"key":"10.1016\/bs.enz.2015.09.003_bb0495","first-page":"245","article-title":"Effects of the PAF-antagonist CV-3988 on PAF-induced changes in mucus secretion and in respiratory and circulatory variables in ferrets","volume":"21","author":"Lang","year":"1987","journal-title":"Agents Actions"},{"key":"10.1016\/bs.enz.2015.09.003_bb0500","first-page":"422","article-title":"Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues","volume":"46","author":"Humphrey","year":"1982","journal-title":"Lab. Invest."},{"key":"10.1016\/bs.enz.2015.09.003_bb0505","first-page":"107","article-title":"PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils","volume":"1","author":"Pirotzky","year":"1984","journal-title":"Microcirc. Endothelium Lymphatics"},{"key":"10.1016\/bs.enz.2015.09.003_bb0510","first-page":"617","article-title":"Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor antagonist","volume":"52","author":"Hwang","year":"1985","journal-title":"Lab. Invest."},{"key":"10.1016\/bs.enz.2015.09.003_bb0515","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF02028109","article-title":"Induction by aerosol allergen of sustained and nonspecific IgE-mediated airway hyperreactivity in the guinea pig","volume":"37","author":"Handley","year":"1992","journal-title":"Agents Actions"},{"key":"10.1016\/bs.enz.2015.09.003_bb0520","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0091-6749(85)90452-X","article-title":"Platelet-activating factor in sputum of patients with asthma and COPD","volume":"44","author":"Grandel","year":"1985","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0525","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1183\/09031936.93.03040408","article-title":"Platelet-activating factor in bronchoalveolar lavage fluid from asthmatic subjects","volume":"3","author":"Stenton","year":"1990","journal-title":"Eur. Respir. J."},{"key":"10.1016\/bs.enz.2015.09.003_bb0530","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1398-9995.1994.tb00775.x","article-title":"Increased levels of blood platelet-activating factor in bronchial asthmatic patients with active symptoms","volume":"49","author":"Kurosawa","year":"1994","journal-title":"Allergy"},{"key":"10.1016\/bs.enz.2015.09.003_bb0535","first-page":"22","article-title":"Increased plasma level of platelet-activating factor (PAF) and decreased serum acetylhydrolase (PAFAH) activity in adults with bronchial asthma","volume":"6","author":"Tsukioka","year":"1996","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0540","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/0091-6749(93)90271-G","article-title":"Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy","volume":"91","author":"Hsieh","year":"1993","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0545","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0091-6749(91)90386-3","article-title":"The release of platelet-activating factor into plasma during allergen-induced bronchoconstriction","volume":"87","author":"Chan-Yeung","year":"1991","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0550","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1165\/ajrcmb.10.5.8179916","article-title":"Expression of platelet-activating factor receptor mRNA in human and guinea pig lung","volume":"10","author":"Shirasaki","year":"1994","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0245","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1172\/JCI5574","article-title":"Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma","volume":"103","author":"Stafforini","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.enz.2015.09.003_bb0250","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1164\/ajrccm.159.3.9807093","article-title":"Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma","volume":"159","author":"Satoh","year":"1999","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"10.1016\/bs.enz.2015.09.003_bb0255","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s100380200009","article-title":"Evidence for an association between plasma platelet-activating factor acetylhydrolase deficiency and increased risk of childhood atopic asthma","volume":"47","author":"Ito","year":"2002","journal-title":"J. Hum. Genet."},{"key":"10.1016\/bs.enz.2015.09.003_bb0555","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/geno.2000.6201","article-title":"Significant evidence for linkage of mite-sensitive childhood asthma to chromosome 5q31-q33 near the interleukin 12B locus by a genome-wide search in Japanese families","volume":"66","author":"Yokouchi","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/bs.enz.2015.09.003_bb0560","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1164\/ajrccm.156.1.9608084","article-title":"Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage","volume":"156","author":"Triggiani","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/bs.enz.2015.09.003_bb0565","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.164.6.3360","article-title":"Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model","volume":"15","author":"Henderson","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0570","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/ajrccm.162.2.9911084","article-title":"Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses","volume":"162","author":"Henig","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/bs.enz.2015.09.003_bb0575","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11882-004-0056-7","article-title":"Oxidative stress in the pathogenesis of asthma","volume":"4","author":"Bowler","year":"2004","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/bs.enz.2015.09.003_bb0580","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1164\/rccm.201405-0948OC","article-title":"New risk factors for adult-onset incident asthma, a nested case-control study of host antioxidant defense","volume":"191","author":"Larkin","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/bs.enz.2015.09.003_bb0585","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ana.410400405","article-title":"Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders","volume":"40","author":"Kira","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0590","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0165-5728(98)00246-X","article-title":"Platelet-activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis","volume":"94","author":"Callea","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0260","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jneuroim.2004.01.008","article-title":"Platelet-activating factor acetylhydrolase gene polymorphism and its activity in Japanese patients with multiple sclerosis","volume":"150","author":"Osoegawa","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/bs.enz.2015.09.003_bb0595","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.fertnstert.2009.06.022","article-title":"Altered distribution of plasma platelet-activating factor acetylhydrolase between high-density lipoprotein and low-density lipoprotein in patients with polycystic ovary syndrome","volume":"92","author":"Fan","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/bs.enz.2015.09.003_bb0265","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/humrep\/deq047","article-title":"Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome","volume":"25","author":"Fan","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/bs.enz.2015.09.003_bb0600","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/humrep\/del003","article-title":"Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin","volume":"21","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/bs.enz.2015.09.003_bb0270","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1046\/j.1523-1755.1998.00215.x","article-title":"Platelet-activating factor acetylhydrolase gene mutation in Japanese nephritic children","volume":"54","author":"Xu","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/bs.enz.2015.09.003_bb0275","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpeds.2005.03.037","article-title":"A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease","volume":"147","author":"Minami","year":"2005","journal-title":"J. Pediatr."},{"key":"10.1016\/bs.enz.2015.09.003_bb0280","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3233\/JAD-2010-100513","article-title":"Genetic deficiency of plasma lipoprotein-associated phospholipase A2(PLA2G7 V279F null mutation) and risk of Alzheimer's disease in Japan","volume":"21","author":"Koshy","year":"2010","journal-title":"J. Alzheimers Dis."}],"container-title":["The Enzymes","Platelet-Activating Factor Acetylhydrolases (PAF-AH)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604715000256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604715000256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:06:45Z","timestamp":1761743205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874604715000256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9780128039083"],"references-count":120,"URL":"https:\/\/doi.org\/10.1016\/bs.enz.2015.09.003","relation":{},"ISSN":["1874-6047"],"issn-type":[{"type":"print","value":"1874-6047"}],"subject":[],"published":{"date-parts":[[2015]]}}}